Mental Health

Reviva to Participate in the 2025 BIO CEO & Investor Conference

CUPERTINO, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage…

11 months ago

TimelyCare Named One of Princeton Review’s Top Five “Need to Know” Mental Health Organizations

FORT WORTH, Texas, Jan. 29, 2025 /PRNewswire/ -- TimelyCare, higher education's most trusted virtual health and well-being provider, is included…

11 months ago

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression

Advancing mental health treatment through innovative research, offering insights on symptom improvement and clinical toolsMALVERN, Pa., Jan. 29, 2025 (GLOBE…

11 months ago

HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”)…

11 months ago

Optimi Health Completes Largest MDMA Capsule Batch to Date, Expands Stability Program

Over 4,000 GMP Capsules Ready to Support PTSD Treatment in Australia, Israel, and CanadaVancouver, British Columbia--(Newsfile Corp. - January 29,…

11 months ago

Optimi Health Announces Closing of Non-Brokered Private Placement and Debt Settlement

Vancouver, British Columbia--(Newsfile Corp. - January 28, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or…

11 months ago

Global Wellness Summit Releases 10 Wellness Trends for 2025

In a polarized wellness market, we'll see both "analog wellness" (a great logging off and seizing of pre-digital experiences) and…

11 months ago

Braviant Supports Mental Health Awareness with a Donation to UnLockeTheLight Foundation

CHICAGO, Jan. 28, 2025 /PRNewswire/ -- Braviant is proud to announce a contribution to the UnLockeTheLight Foundation during the 7th…

11 months ago

New Survey from Aeroflow Sleep Reveals Disparities Around Women’s Sleep Health

The proprietary survey found 60% of women feel their sleep is negatively impacting their day-to-day activities, yet more than half…

11 months ago

60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis

Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment of patients with…

11 months ago